MEDIF MediPharm Labs Corp.

MediPharm Labs Corp., together with its subsidiaries, produces and sells pharmaceutical-grade cannabis oil and concentrates for derivative products in Canada and Australia. It also provides cannabis contract processing services to licensed producers and growers; and tolling services to licensed cultivators in Canada. In addition, the company supplies purified cannabis concentrate raw materials and product formulations for ready-to-sell advanced cannabis products. Further, it engages in the real estate business. The company was founded in 2015 and is headquartered in Barrie, Canada.

Note: This is not a U.S. company, but they cross-list their shares on the U.S. over-the-counter market - see the related symbol CT:LABS.

$0.17    OTCQX
As of 11/29/2021     OTCMarkets


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  Canada
Country of incorporation:  
IPO date:  10/05/2018
Outstanding shares:  266,498,281
Average volume:  196,878
Market cap:   $45,837,704
Current dividend yield:  0.00%
CUSIP:    
ISIN:        
Sedol:      
Valuation   (See tab for details)
PE ratio:   -0.72
PB ratio:   0.44
PS ratio:   2.08
Return on equity:   -62.35%
Net income %:   -290.50%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy